Cargando…

Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?

BACKGROUND: The delivery of a simultaneous integrated boost to the intra-prostatic tumour nodule may improve local control. The ability to deliver such treatments with hypofractionated SBRT was attempted using RapidArc (Varian Medical systems, Palo Alto, CA) and Multiplan (Accuray inc, Sunnyvale, CA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tree, Alison, Jones, Caroline, Sohaib, Aslam, Khoo, Vincent, van As, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853231/ https://www.ncbi.nlm.nih.gov/pubmed/24088319 http://dx.doi.org/10.1186/1748-717X-8-228

Ejemplares similares

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
por: Nicholls, Luke, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016)

Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer
por: Henderson, Daniel R., et al.
Publicado: (2018)

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer
por: Lin, Yu-Wei, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
por: Nakamura, Akira, et al.
Publicado: (2019)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
por: Kim, Hun Jung, et al.
Publicado: (2015)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison
por: Dahbi, Zineb, et al.
Publicado: (2023)

Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
por: Eckl, Miriam, et al.
Publicado: (2021)

Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast‐rotating O‐ring linac: Plan quality comparison with C‐arm linacs
por: De Roover, Robin, et al.
Publicado: (2021)

Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer
por: Levin-Epstein, Rebecca, et al.
Publicado: (2020)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
por: Pontoriero, Antonio, et al.
Publicado: (2020)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

Planning study: prone versus supine position for stereotactic body radiotherapy in prostate by CyberKnife
por: Kon, Mitsuhiro, et al.
Publicado: (2022)

Plan comparison of prostate stereotactic radiotherapy in spacer implant patients
por: Oki, Yuya, et al.
Publicado: (2021)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Stereotactic body radiotherapy for organ-confined prostate cancer
por: Katz, Alan J, et al.
Publicado: (2010)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Prostate stereotactic body radiotherapy: quantifying intra-fraction motion and calculating margins using the new BIR geometric uncertainties in daily online IGRT recommendations
por: McNeice, Joseph M, et al.
Publicado: (2023)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
por: Pathmanathan, Angela U., et al.
Publicado: (2019)

Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor
por: Watcharawipha, Anirut, et al.
Publicado: (2023)

A RapidArc planning strategy for prostate with simultaneous integrated boost
por: Jolly, David, et al.
Publicado: (2010)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
por: Pepin, Abigail N., et al.
Publicado: (2022)

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
por: Kim, Yeon Joo, et al.
Publicado: (2020)

A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation
por: Xia, Ping, et al.
Publicado: (2016)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
por: Aluwini, Shafak, et al.
Publicado: (2013)

Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy
por: Miura, Hideharu, et al.
Publicado: (2014)

Questionnaire survey on treatment planning techniques for lung stereotactic body radiotherapy in Japan
por: Ueda, Yoshihiro, et al.
Publicado: (2020)

Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate
por: Bansal, A., et al.
Publicado: (2012)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6lsfklucvmm4c5npc512dr5e4u